Biocytogen
Boston, United States· Est.
Biocytogen develops genetically engineered mouse models and antibody discovery platforms for preclinical research and therapeutic development.
Private Company
Total funding raised: $170M
About
Biocytogen develops genetically engineered mouse models and antibody discovery platforms for preclinical research and therapeutic development.
Genetics & Genomics
Funding History
2Total raised:$170M
Series C$105M
Series B$65M